Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bologna
Clinical trial register · Italy

Clinical Trials in Bologna, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna306 Istituto Ortopedico Rizzoli106 AstraZeneca45 Eli Lilly and Company30 Janssen Research & Development, LLC26
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Bologna

1303 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Merck Sharp & Dohme LLC
Phase 2
355
Naples, Milan, Siena, Bologna, Brescia, Verona
2021-08-12
Active, closed
Pfizer
Phase 3
118
Bergamo, Naples, Roma, Bologna
2021-08-12
Active, closed
HUYABIO International, LLC.
Phase 3
450
Milan, Perugia, Bari, Bologna, Misterbianco, Naples, Palermo, Roma
2021-08-12
Active, closed
MedSIR
Phase 2
393
Bologna, Milan, Monza, Parma, Piacenza, Roma
2021-08-05
Recruiting
Observational Study in Localized Osteosarcoma
NCT04890067Localized Osteosarcoma
Italian Sarcoma Group
Observational
120
Aviano, Candiolo, Trieste, Bari, Bologna, Catania, Florence, Genova
2021-07-30
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
12
Bologna
2021-07-18
Recruiting
Valved Graft PMCF Study
NCT04754217Aortic Valve Disease, Ascending Aorta Abnormality, Aortic Dissection
Abbott Medical Devices
Observational
260
Bologna, Milan, San Donato Milanese
2021-07-13
Active, closed
VectivBio AG
Phase 3
158
Bologna, Rome, Turin
2021-07-13
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
100
Bologna
2021-07-10
Recruiting
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
NCT04613921Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications
European Foundation for Study of Chronic Liver Failure
Observational
3,000
Bergamo, Bologna, Milan, Padova
2021-07-08
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 3
434
Bologna, Meldola, Milan, Pisa, Verona
2021-07-06
Recruiting
Enterome
Phase 1/2
80
Bologna, Naples, Pavia
2021-07-05
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
80
Bologna
2021-07-01
Recruiting
Health-care Quality in Semi-intensive Care Units
NCT04676347Semi-intensive Care Unit, Evaluation, Quality
Mario Negri Institute for Pharmacological Research
Observational
39,000
Milan, Alessandria, Bassano del Grappa, Bologna, Catania, Cesena, Livorno, Lodi
2021-07-01
Active, closed
AstraZeneca
Phase 3
315
Bergamo, Bologna, Florence, Meldola, Milan, Misterbianco, Naples, Padova
2021-06-30
Active, closed
Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS
NCT05027984Coronary Artery Disease, Coronary Disease, Ischemic Heart Disease
Centro per la Lotta Contro l'Infarto - Fondazione Onlus
Not applicable
1,425
Ascoli Piceno, Acquaviva delle Fonti, Bari, Bergamo, Benevento, Bologna, Cagliari, Aversa
2021-06-30
Recruiting
Corcym S.r.l
Observational
2,150
Ancona, Bologna, Brescia, Lecce, Massa, Milan, Naples, Palermo
2021-06-29
Active, closed
GlaxoSmithKline
Phase 3
40
Ancona, Bologna, Brindisi, Candiolo to, Catania, Genova, Meldola FC, Milan
2021-06-28
Active, closed
Neurocrine Biosciences
Phase 3
103
Bologna, Milan, Naples, Roma
2021-06-25
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
520
Bologna, Milan, Pisa, Roma
2021-06-15
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
300
Bologna
2021-06-15
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
180
Bologna
2021-06-14
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
440
Bologna
2021-06-10
Recruiting
Genome Analysis of Human Endogenous Retroviruses (HERVs)(COVID19)
NCT06775457SARS CoV-2, Kawasaki Disease, Retrovirus Infection
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
120
Carpi, Bologna, Modena, Roma, Torino
2021-06-10
Active, closed
Galecto Biotech AB
Phase 2
21
Bologna, Florence, Milan, Orbassano, Varese
2021-06-09
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not applicable
72
Bologna, Bolzano, Castelfranco Veneto, San Giovanni Rotondo, Treviso
2021-06-09
Active, closed
St. Olavs Hospital
Not applicable
200
Bologna
2021-06-07
Active, closed
University Hospital of Ferrara
Not applicable
249
Ferrara, Bologna, Forlì, Palermo, Ravenna, Rimini, Trieste
2021-06-03
Active, closed
Daiichi Sankyo
Phase 2
155
Bergamo, Bologna, Monza, Naples, Perugia
2021-06-03
Recruiting
Observational Study on Skeletal Ewing's Sarcoma
NCT04845893Ewing Sarcoma of Bone
Italian Sarcoma Group
Observational
100
Rozzano, Aviano, Candiolo, Bari, Bologna, Florence, Genova, Milan
2021-06-01
Recruiting
Trifecta-Heart cfDNA-MMDx Study
NCT04707872Heart Transplant Rejection
University of Alberta
Observational
300
Bologna
2021-06-01
Recruiting
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
NCT04844606Ulcerative Colitis, Ulcerative Colitis Chronic, Inflammatory Bowel Diseases, Crohn's Disease
DrugMirikizumab
Eli Lilly and Company
Phase 3
150
Bergamo, Bologna, Florence, Milan, Roma, Rome
2021-05-26
Recruiting
Poor Grade Aneurysmal Subarachnoid Hemorrhage Study Group
NCT04945603Subarachnoid Hemorrhage, Aneurysmal, Poor Grade Subarachnoid Hemorrhage
IRCCS San Raffaele
Observational
800
Bergamo, Bologna, Brescia, Lecce, Milan, Novara, Parma, Roma
2021-05-25
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
NCT04771130Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasm
DrugsPosaconazole·Sonrotoclax·Azacitidine
BeOne Medicines
Phase 1/2
260
Bologna, Meldola, Milan
2021-05-24
Recruiting
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
NCT04503395Aortic Aneurysm, Abdominal
FCRE (Foundation for Cardiovascular Research and Education)
Not applicable
204
Bologna, Genova, Milan, Perugia, Turin, Verona
2021-05-21
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna, San Giovanni Rotondo, Bari, Cagliari, Novara, Palermo, Reggio Emilia, Terni
2021-05-20
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
94
Bologna
2021-05-20
Active, closed
Alectinib in Neo-adjuvant Treatment of Stage III NSCLC
NCT05015010Non Small Cell Lung Cancer
DrugAlectinib
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
33
Meldola, Lido di Camaiore, Monza, Aviano, Orbassano, Bari, Bologna, Catania
2021-05-20
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
3,000
Bologna
2021-05-19
Active, closed
CNS Pharmaceuticals, Inc.
Phase 2
252
Bologna, Milan
2021-05-18
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
150
Bologna
2021-05-14
Active, closed
Pfizer
Phase 3
599
Bologna, Cremona, Meldola, San Giovanni Rotondo, Naples, Aviano, Trento, Arezzo
2021-05-12
Active, closed
Azienda USL Reggio Emilia - IRCCS
Observational
700
Reggio Emilia, Bologna, Ferrara, Forlì, Modena, Parma, Rimini
2021-05-10
Active, closed
AstraZeneca
Phase 3
893
Bologna, Florence, Misterbianco, Naples, Padova, Prato, Roma
2021-05-10
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna
2021-05-06
Active, closed
Hoffmann-La Roche
Phase 2
586
Naples, Salerno, Bologna, Rome, Genoa, Brescia, Milan, Pozzilli (IS)
2021-05-05
Active, closed
Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse
NCT04475731Philadelphia-Positive ALL, Acute Lymphoblastic Leukemia, in Relapse
DrugPonatinib
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
67
Ancona, Ascoli Piceno, Avellino, Bari, Bergamo, Bologna, Brescia, Cuneo
2021-05-04
Active, closed
Hoffmann-La Roche
Phase 3
761
Naples, Bologna, Meldola, Rome, Genoa, Milan, Orbassano, Arezzo
2021-05-03
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
69
Bologna
2021-04-30
Active, closed
Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination
NCT04868877Non-Small Cell Lung Cancer Metastatic, Gastric Cancer, Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma
DrugsBispecific·Tagrisso·Osimertinib
Merus B.V.
Phase 1/2
194
Roma, Bologna, Brescia, Milan, Orbassano, Salerno, Verona
2021-04-28
Active, closed
Hoffmann-La Roche
Phase 3
557
Naples, Bologna, Rome, Milan, Turin, Palermo, Florence, Pisa
2021-04-26
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
180
Bologna
2021-04-21
Recruiting
Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study
NCT06774690HCC - Hepatocellular Carcinoma, Cholangiocarcinoma Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
3,300
Bologna
2021-04-21
Active, closed
Geron Corporation
Phase 3
327
Alessandria, Bologna, Cona, Florence, Genova, Milan, Ravenna, Reggio Calabria
2021-04-12
Active, closed
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
NCT04603495Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
430
Bergamo, Bologna, Brescia, Ferrara, Florence, Meldola, Milan, Monza
2021-04-09
Active, closed
Loxo Oncology, Inc.
Phase 3
500
Alessandria, Meldola, Ravenna, Milan, Bologna, Genova, Palermo, Potenza
2021-04-08
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
94
Bologna
2021-04-07
Recruiting
Ente Ospedaliero Cantonale, Bellinzona
Observational
1,500
Bologna
2021-04-06
Active, closed
Uterus Transplantation: Acceptability of the Procedure in Eligible Patients
NCT06799728Focus: Uterus Transplant Procedure, Acceptability of the Uterus Transplantation Procedure
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
150
Bologna
2021-04-05
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
DrugNemtabrutinib
Merck Sharp & Dohme LLC
Phase 2
490
Bari, Bologna, Brescia, Milan, Naples, Pavia, Reggio Emilia, Roma
2021-04-05
Active, closed
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
NCT04722250Symptomatic Aortic Stenosis, Aortic Valve Stenosis, Aortic Valve Replacement
Medtronic Cardiovascular
Not applicable
1,103
Bologna, Pisa, Verona
2021-04-02
Recruiting
Italian Sarcoma Group
Observational
300
Bologna, Milan, Rozzano, Palermo, Aviano, Prato, Roma, Candiolo
2021-04-02
Active, closed
Novo Nordisk A/S
Phase 3
1,205
Catanzaro, San Giovanni Rotondo, Palermo, Bologna, Florence, Foggia, Milan, Roma
2021-04-01
Recruiting
Liver Transplantation for Non-Resectable Colorectal Liver Metastasis
NCT05185245Liver Metastasis Colon Cancer, Colorectal Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
20
Bologna
2021-04-01
Recruiting
Observational Study to Develop a Predictive Score for Adverse Events Post ERCP
NCT06776874Endoscopic Retrograde Cholangiopancreatography
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
981
Bologna
2021-03-24
Active, closed
Bristol-Myers Squibb
Phase 1/2
216
Bologna, Brescia, Florence, Verona
2021-03-22
Active, closed
Verici Dx
Observational
550
Bologna, Brescia
2021-03-21
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
350
Bologna
2021-03-17
Recruiting
Fondazione EMN Italy Onlus
Observational
1,900
Florence, Ancona, Bari, Bologna, Brescia, Catania, Genova, Milan
2021-03-16
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
150
Bologna
2021-03-01
Recruiting
Istituto Ortopedico Rizzoli
Phase 2
67
Bologna
2021-03-01
Active, closed
Celgene
Phase 3
313
Meldola (fc), Ancona, Bologna, Brescia, Catania, Florence, Milan, Napoli Campania
2021-02-25
Recruiting
Treosulfan Therapeutic Drug Monitoring in Pediatric Hematopoietic Stem Cell Transplant Recipients
NCT06861257Pediatric Hematopoietic Stem Cell Transplantation, Malignant Disorders, Non-malignant Disorders
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
70
Bologna, Brescia, Genova, Milan, Monza, Padova, Pavia, Torino
2021-02-24
Active, closed
Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms
NCT04279847Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome, Myeloproliferative Neoplasm
DrugRuxolitinib
Incyte Corporation
Phase 1
140
Bologna, Florence, Meldola, Milan, Orbassano, Verona
2021-02-23
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase 4
50
Bologna, Naples, Padova
2021-02-23
Active, closed
Stichting European Myeloma Network
Phase 2
160
Ancona, Bologna, Bolzano, Brescia, Florence, Genova, Pavia, Terni
2021-02-22
Active, closed
Istituto Ortopedico Rizzoli
Not applicable
100
Bologna
2021-02-22
Recruiting
Analysis of Patients With Autosomal Dominant Polycystic Kidney
NCT06759142Autosomal Dominant Polycystic Kidney, ADPKD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
180
Bologna
2021-02-20
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
6,600
Bologna
2021-02-08
Recruiting
Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia
NCT06833593Enterococcus Faecalis Infection, Blood Stream Infection, Gut Microbiomes
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
510
Bologna, Catanzaro, Milan
2021-02-06
Recruiting
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
NCT04761120Mitral Regurgitation, Tricuspid Regurgitation, Valvular Heart Disease
Abbott Medical Devices
Observational
550
Bologna, Milan, Turin
2021-02-01
Recruiting
Infusion of Alloreactive nk Cells for Mrd-positive Aml Patients
NCT06885476Acute Myeloid Leukemia, Minimal Residual Disease, Natural Killer Cell
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
22
Bologna
2021-01-22
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
7,000
Bologna
2021-01-21
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
200
Bologna
2021-01-11
Active, closed
Amgen
Phase 1/2
181
Bergamo, Bologna, Brescia, Catania, Milan, Naples, Roma
2021-01-04
Active, closed
AstraZeneca
Phase 1/2
245
Bologna, Milan, Naples, Rome
2020-12-28
Active, closed
IRCCS San Raffaele Roma
Not applicable
70
Bologna, Ferrara, Foggia, Messina, Roma, Rome, San Giovanni Rotondo
2020-12-28
Active, closed
Daiichi Sankyo
Phase 3
605
Bologna, Catania, Genova, Milan, Orbassano, Roma
2020-12-21
Active, closed
Mirum Pharmaceuticals, Inc.
Phase 2
182
Bologna, Milan, Monza, Naples, Padova
2020-12-18
Recruiting
ACL Reconstruction: Clinical Outcome
NCT03441659ACL Injury
Stefano Zaffagnini
Observational
1,000
Bologna
2020-12-17
Active, closed
Neurocrine Biosciences
Phase 3
182
Ancona, Bologna, Florence, Messina, Milan, Naples, Padova, Roma
2020-12-16
Recruiting
Teknimed
Observational
1,050
Bologna, Cento
2020-12-16
Active, closed
Daiichi Sankyo
Phase 3
1,600
Catania, Milan, Ancona, Aviano, Bari, Belluno, Bologna, Brindisi
2020-12-04
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Aviano, Bari, Bologna, Brescia, Candiolo, Florence, Genova, Meldola
2020-12-02
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
50
Bologna
2020-11-30
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
50
Bologna
2020-11-30
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
274
Alessandria, Ancona, Ascoli Piceno, Bari, Bologna, Brescia, Brindisi, Castelfranco Veneto
2020-11-27
Active, closed
Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome
NCT04623541Relapsed/Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome, Treatment-naïve High Risk Chronic Lymphocytic Leukemia
DrugsEpcoritamab·Pirtobrutinib·Lenalidomide·Venetoclax
Genmab
Phase 1/2
194
Bologna, Torino, Ferrara, Meldola, Rome, Roma, Brescia, Milan
2020-11-25
Recruiting
Study of Parameters of Osteosarcopenia in Patients With Hip Fracture
NCT04730622Osteoporotic Fracture of Femur, Osteoarthritis, Hip
Istituto Ortopedico Rizzoli
Observational
100
Bologna
2020-11-23
Active, closed
Janssen Pharmaceutica N.V., Belgium
Phase 3
691
Bologna, Florence, Milan, Roma
2020-11-12
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
180
Bologna
2020-11-09
Recruiting
Meril Life Sciences Pvt. Ltd.
Not applicable
988
Bologna, Catania, Milan, Tortona, Turin
2020-11-04
Active, closed
Associazione Italiana per lo Studio del Pancreas
Phase 3
261
Aviano, Bari, Bergamo, Bologna, Brescia, Florence, Meldola, Milan
2020-11-03
Active, closed
Genmab
Phase 1/2
543
Bergamo, Bologna, Candiolo, Meldola, Milan, Pavia, Reggio Emilia
2020-11-03
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
50
Bologna
2020-10-22
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
350
Bologna
2020-10-13
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Bologna, Catania, Meldola, Milan, Monza, Ravenna, Roma, Rozzano
2020-10-13
Recruiting
Luca Sangiorgi
Observational
1,000
Bologna
2020-10-10
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
180
Bologna
2020-10-09
Active, closed
Metabolic Control and Glycemic Variability in Type 1 Diabetes and Celiac Disease
NCT06717841Type 1 Diabetes Mellitis, Celiac Disease
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
200
Bologna
2020-10-09
Active, closed
Acerta Pharma BV
Phase 3
611
Bari, Bergamo, Bologna, Florence, Genova, Meldola, Milan, Novara
2020-10-08
Active, closed
GlaxoSmithKline
Phase 3
302
Bologna, Milan, Pavia, Roma
2020-10-01
Recruiting
Functional Instability in Patients Suffering From Collagen Disease and Joint Hypermobility
NCT05871216Hypermobility Syndrome, Danlos Disease, Ehlers, Collagen Diseases, Joint Hypermobility
Istituto Ortopedico Rizzoli
Observational
30
Bologna
2020-10-01
Active, closed
AbbVie
Phase 3
527
Bologna, Genoa, Milan, Rho, Rome, Negrar, Cagliari, Palermo
2020-09-30
Active, closed
European Myeloma Network B.V.
Phase 3
302
Ancona, Bari, Bologna, Brescia, Cuneo, Florence, Novara, Pavia
2020-09-25
Active, closed
Ipsen
Phase 3
161
Modena, Bologna, Milan, Monza, Padova, Palermo
2020-09-24
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
414
Alessandria, Ancona, Ascoli Piceno, Avellino, Bari, Bologna, Caserta, Castelfranco Veneto
2020-09-24
Recruiting
University of Bologna
Observational
2,000
Bologna
2020-09-20
Active, closed
Janssen Research & Development, LLC
Phase 2
194
Bergamo, Bologna, Milan
2020-09-17
Active, closed
AbbVie
Phase 3
531
Rozzano, Naples, Rome, Bologna, Reggio Calabria
2020-09-10
Active, closed
AbbVie
Phase 3
330
Bologna, Florence, Rome, Monza, Naples, Turin, Ancona, Bergamo
2020-08-31
Active, closed
Philogen S.p.A.
Phase 2
98
Bologna, Candiolo, Orbassano, Roma
2020-08-28
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
239
Bari, Tricase, Milan, Bologna, Trieste
2020-08-20
Recruiting
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
NCT04575935Advanced Ovarian Carcinoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Serous Neoplasm
M.D. Anderson Cancer Center
Phase 3
580
Bologna, Rome
2020-08-05
Active, closed
AstraZeneca
Phase 3
185
Ancona, Bologna, Brescia, Candiolo, Catania, Lecce, Lecco, Milan
2020-08-04
Active, closed
Incyte Corporation
Phase 2
112
Bologna, Florence, Meldola (FC), Milan, Naples, Novara, Palermo, Pisa
2020-08-03
Active, closed
Medtronic
Observational
2,200
Bologna, Cosenza, Lecce, Milan, Taranto, Udine
2020-08-01
Active, closed
Medtronic
Observational
2,200
Bologna, Castrovillari, Lecce, Milan, Taranto, Udine
2020-08-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
50
Bologna
2020-07-21
Active, closed
AstraZeneca
Phase 3
134
Bologna
2020-07-20
Recruiting
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
NCT03651206Ovarian Carcinosarcoma, Endometrial Carcinosarcoma
DrugNiraparib
ARCAGY/ GINECO GROUP
Phase 2/3
138
Bologna, Catania, Meldola, Milan, Naples, Roma, Torino
2020-07-15
Recruiting
University of Turin, Italy
Not applicable
416
Grosseto, Sesto San Giovanni, La Spezia, Candiolo, Pinerolo, Bologna, Ferrara, Genova
2020-07-13
Recruiting
Bilateral Bispectral Index, Asymmetries and Post-operative Delirium
NCT06761573Postoperative Delirium, Postoperative Cognitive Dysfunction
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
84
Bologna
2020-07-07
Recruiting
Registry of Li Fraumeni and Li Fraumeni Like Syndromes
NCT04982744Li-Fraumeni Syndrome, Li-Fraumeni-Like Syndrome
Istituto Ortopedico Rizzoli
Observational
200
Bologna
2020-07-02
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
600
Bologna
2020-06-30
Active, closed
Sanofi
Phase 3
337
Meldola, Rozzano, Ancona, Bologna, Terni
2020-06-16
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Bologna, Milan, Roma, Turin
2020-06-12
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
572
Alessandria, Asti, Bari, Bologna, Cagliari, Florence, Milan, Modena
2020-05-29
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
500
Bologna
2020-05-28
Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
NCT04256317Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm, Chronic Myelomonocytic Leukemia
DrugsVenclexta·Azacitidine·Venetoclax
Taiho Oncology, Inc.
Phase 2/3
316
Ravenna, Florence, Torino, Bologna, Milan, Novara, Roma
2020-05-21
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Observational
300
Meldola, Ravenna, Bologna, Rimini
2020-05-14
Active, closed
AstraZeneca
Phase 2
240
Bologna, Catanzaro, Meldola, Messina, Milan, Monza, Naples, Roma
2020-04-22
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
300
Cesena, Forlì, Bologna, Ravenna, Rimini
2020-04-21
Active, closed
GlaxoSmithKline
Phase 3
325
Bologna, Brescia, Catanzaro, Milan, Pavia, Perugia, Ravenna, Roma
2020-04-02
Active, closed
University Hospital of Ferrara
Not applicable
512
Bologna, Ferrara, Piacenza, Lagosanto
2020-03-27
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
50
Bologna
2020-03-20
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
150
Bologna
2020-03-18
Active, closed
UMC Utrecht
Not applicable
216
Bologna, Roma
2020-03-10
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
150
Bologna
2020-03-05
Recruiting
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
NCT04294927BRCA1 Gene Mutation, BRCA2 Gene Mutation, RAD51C Gene Mutation, RAD51D Gene Mutation
University Medical Center Nijmegen
Not applicable
3,000
Bologna, Milan, Monza, Rome
2020-03-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
755
Verona, Arezzo, Bari, Bologna, Milan, Modena, Padova, Pavia
2020-02-27
Recruiting
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
NCT03934372Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia, Chronic Phase Chronic Myeloid Leukemia
DrugPonatinib
Incyte Biosciences International Sàrl
Phase 1/2
70
Bologna, Brescia, Genova, Milan, Monza, Naples, Pavia, Rome
2020-01-29
Recruiting
Eli Lilly and Company
Phase 2
105
Bologna, Candiolo, Milan, Padova, Roma, Rozzano
2020-01-22
Active, closed
BeOne Medicines
Phase 3
955
Bologna, Meldola, Milan, Modena, Novara, Ravenna, Roma, Terni
2020-01-16
Active, closed
Actelion
Phase 3
138
Bologna, Milan, Padova, Roma, S. Donato Milanese, Torino
2020-01-16
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
50
Bologna
2020-01-11
Active, closed
Advanced Accelerator Applications
Phase 3
226
Bologna, Genova, Meldola, Milan, Naples, Reggio Emilia, Roma
2020-01-08
Active, closed
Institut de Recherches Internationales Servier
Phase 3
331
Turin, Bologna, Padua, Roma, Rozzano
2020-01-05
Active, closed
The Netherlands Cancer Institute
Phase 3
538
Bologna, Roma
2020-01-01
Active, closed
Galderma R&D
Phase 3
1,700
Bologna, L’Aquila, Roma, Rome, Rozzano, Vicenza
2019-12-30
Active, closed
GlaxoSmithKline
Phase 1
118
Bologna, Meldola FC
2019-12-18
Recruiting
Sumitomo Pharma America, Inc.
Phase 1/2
240
Alessandria, Aviano, Bologna, Brescia, Meldola, Milan, Torino
2019-12-16
Active, closed
Gruppo Italiano Trapianto di Midollo Osseo
Phase 2
100
Brescia, San Giovanni Rotondo, Tricase, Monza, Ancona, Ascoli Piceno, Bari, Bologna
2019-12-09
Active, closed
Gruppo Italiano Trapianto di Midollo Osseo
Phase 2
120
Cagliari, Naples, Ancona, Bari, Bologna, Brescia, Cuneo, Florence
2019-12-06
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
Milan, Bologna, Livorno, Novara, Perugia, Ravenna, Reggio Emilia, Varese
2019-11-13
Active, closed
AbbVie
Phase 1/2
218
Bologna, Milan, Novara, Meldola
2019-11-06
Recruiting
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
NCT04065399Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Mixed Lineage Acute Leukemia, Mixed Phenotype Acute Leukemia
DrugsCobicistat·Revumenib
Syndax Pharmaceuticals
Phase 1/2
447
Bologna, Meldola, Milan, Roma, Vicenza
2019-11-05
Active, closed
Stichting European Myeloma Network
Phase 2
41
Bologna, Torino
2019-10-31
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
76
Ancona, Ascoli Piceno, Bergamo, Bologna, Bolzano, Brescia, Cuneo, Genova
2019-10-30
Recruiting
Associazione Italiana Ematologia Oncologia Pediatrica
Phase 2
89
San Giovanni Rotondo, Bari, Bergamo, Bologna, Cagliari, Catania, Florence, Genova
2019-10-09
Active, closed
Niguarda Hospital
Phase 2
28
Alessandria, Bergamo, Bologna, Brescia, Milan, Novara, Pavia, Roma
2019-10-04
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
466
Torrette, Bologna, Rome, Faenza, Lugo, Cattolica, Milan, Ravenna
2019-10-02
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,064
Bologna, Milan, Negrar, Padova, Palermo, Rho, Roma, Rozzano
2019-09-26
Recruiting
National Database on Primary Biliary Cholangitis
NCT05151809Primary Biliary Cholangitis
University of Milano Bicocca
Observational
6,000
Ancona, Bari, Bergamo, Bologna, Bolzano, Brescia, Cagliari, Castellana Grotte
2019-09-19
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
NCT04104776Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant
DrugsTulmimetostat·Enzalutamide
Novartis Pharmaceuticals
Phase 1/2
300
Bologna, Milan, Roma, Rozzano
2019-09-18
Active, closed
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
NCT04067336Advanced Malignant Neoplasm, Acute Myeloid Leukemia, Mixed Lineage Leukemia, Mixed Lineage Acute Leukemia
DrugsZiftomenib·Itraconazole·Midazolam
Kura Oncology, Inc.
Phase 1/2
263
Bologna, Meldola, Ravenna, Roma
2019-09-12
Not yet open
Hepatocarcinoma Recurrence on the Liver Study - Part2
NCT04053231Liver Cancer, Surgery, Recurrence Tumor, Cirrhosis
University of Milano Bicocca
Observational
3,000
Bari, Bologna, Bolzano, Brescia, Forlì, Lecco, Mantua, Milan
2019-09
Recruiting
University Hospital Muenster
Phase 3
683
Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Catania, Cona
2019-08-23
Active, closed
BeOne Medicines
Phase 3
510
Alessandria, Bologna, Genova, Milan, Novara, Palermo, Pisa, Ravenna
2019-08-20
Active, closed
Sanofi
Observational
1,860
Terracina, Naples, Padua, Bari, Bologna, Brescia, Catania, Milan
2019-08-15
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
Florence, Allessandria, Bologna, Brindisi, Cagliari, Ferrara, Genoa, Lecce
2019-08-12
Active, closed
OncoVerity, Inc.
Phase 2
103
Bologna, Brescia, Meldola, Milan, Naples, Udine
2019-07-29
Active, closed
Consorzio Futuro in Ricerca
Not applicable
1,445
Bologna, Ferrara, Cotignola, Ravenna, Reggio Emilia, Rimini, Agrigento, Caserta
2019-07-15
Recruiting
University of Milano Bicocca
Observational
7,000
Baggiovara, Bologna, Bolzano, Carate Brianza, Ferrara, Florence, Genova, Roma
2019-07-15
Active, closed
Fondazione EMN Italy Onlus
Phase 2
45
Ancona, Bari, Bergamo, Bologna, Brescia, Catania, Milan, Novara
2019-07-01
Recruiting
Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK
NCT04181970Soft-tissue Sarcoma, Gastrointestinal Stromal Tumors, Bone Sarcoma
Grupo Espanol de Investigacion en Sarcomas
Observational
5,000
Bologna, Milan
2019-06-30
By invitation
The International Survey of Acute Coronary Syndromes-ARCHIVES
NCT04008173Acute Coronary Syndrome, Unstable Angina Pectoris, Myocardial Infarction, Coronary Disease
University of Bologna
Observational
130,000
Bologna
2019-06-28
Recruiting
Istituto Ortopedico Rizzoli
Observational
260
Bologna
2019-06-11
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Bergamo, Bologna, Brescia, Florence, L’Aquila, Milan, Naples, Rome
2019-06-04
Recruiting
Protocol ITANET - Registry
NCT04282083Gastro-entero Pancreatic Neuroendocrine Tumors
Italian Association Neuroendocrine Tumors
Observational
3,600
Rozzano, Peschiera del Garda, Ancona, Bari, Bologna, Bolzano, Brescia, Brindisi
2019-05-25
Active, closed
Celgene
Phase 1/2
438
Bergamo, Bologna, Milan, Naples, Pavia
2019-05-20
Active, closed
IDH1 (AG 120) Inhibitor in Patients With IDH1 Mutated Myelodysplastic Syndrome
NCT03503409Myelodysplastic Syndromes, Acute Myeloid Leukemia
DrugIvosidenib
Groupe Francophone des Myelodysplasies
Phase 2
68
Alessandria, Ancona, Bologna, Brescia, Florence, Genova, Lecce, Milan
2019-05-14
Active, closed
European Myeloma Network B.V.
Phase 2
401
Ancona, Bergamo, Bologna, Brescia, Catania, Genova, Milan, Novara
2019-04-16
Active, closed
Blueprint Medicines Corporation
Phase 2
251
Bologna, Milan, Salerno, Verona
2019-04-16
Recruiting
Total Knee Arthroplasty: Fast Track Protocol is the Future?
NCT03869996Osteoarthritis, Knee, Arthropathy of Knee
Istituto Ortopedico Rizzoli
Not applicable
64
Bologna
2019-02-25
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
453
Bologna, Meldola, Milan, Padova, Palermo, Rome
2019-02-08
Active, closed
Xenon Pharmaceuticals Inc.
Phase 2
325
Bologna, Catanzaro, Milan, Pavia, Pisa, Reggio Calabria, Roma
2019-01-30
Active, closed
Celgene
Phase 3
363
Orbassano, Bologna, Florence, Meldola, Milan, Padova, Reggio Calabria, Roma
2019-01-02
Active, closed
W.L.Gore & Associates
Observational
280
Bologna, Brescia, Padova, Varese
2018-12-18
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Ancona, Bergamo, Bologna, Misterbianco, Milan, Rozzano, Palermo, Aviano
2018-12-07
Recruiting
Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas
NCT04621201Diagnosed or Relapsed/Refractory Sarcomas
Azienda Ospedaliera Ospedale Infantile Regina Margherita Sant'Anna
Observational
120
Torino, Bologna, Florence, Genova, Milan, Pavia, Roma, Trieste
2018-12-06
Recruiting
Pulmonary Hemodynamics During Exercise - Research Network
NCT03954574Pulmonary Circulation Diseases
Medical University of Graz
Observational
1,500
Bologna, Roma
2018-12-01
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 2
58
Ancona, Bologna, Brescia, Roma, Torino
2018-11-19
Active, closed
AstraZeneca
Phase 3
1,063
Bari, Bologna, Florence, Milan, Naples, Orbassano, Pozzuoli, Verona
2018-11-16
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Bologna, Florence, Messina, Roma, San Giovanni Rotondo, Trieste
2018-10-29
Active, closed
AbbVie
Phase 3
265
Bologna, Turin, Rionero in Vulture, Ancona, Milan, Palermo, Terni
2018-10-22
Active, closed
Tesaro, Inc.
Phase 3
1,400
Bologna, Faenza, Lugo RA, Meldola FC, Naples
2018-10-11
Active, closed
AbbVie
Phase 2
270
Bologna, Meldola, Milan, Naples, Rome, Orbassano, Avellino, Parma
2018-10-10
Active, closed
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
NCT03589326Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
DrugsPonatinib·Imatinib·Cytarabine·Vincristine
Takeda
Phase 3
245
Meldola, Genoa, Monza, Reggio Emilia, Mestre, Bologna, Lecce, Milan
2018-10-04
Active, closed
AbbVie
Phase 3
1,242
Genoa, Rozzano, Milan, Rho, Rome, Negrar, Bologna, Catania
2018-08-28
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Bologna, Rome, Milan, Monza, Rozzano, Aviano, Catania, Candiolo
2018-08-21
Recruiting
Celgene
Phase 2/3
1,541
Ancona, Bologna, Milan, Monza, Naples, Roma, Rome, Rozzano (MI)
2018-07-19
Recruiting
Martin Schrappe
Phase 3
5,000
Ancona, Bari, Bergamo, Bologna, Brescia, Cagliari, Catania, Catanzaro
2018-07-15
Active, closed
Janssen Research & Development, LLC
Phase 3
120
Ancona, Bologna, Cagliari, Padova, Reggio Emilia
2018-07-11
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Alessandria, Bologna, Candiolo, Meldola, Milan
2018-06-26
Active, closed
Exelixis
Phase 3
837
Tricase, Rozzano, Bologna, Brescia, Milan, Naples, Novara, Roma
2018-06-10
Active, closed
Thoraflex Hybrid Post-Market Study
NCT03414866Acute Aortic Dissection, Aortic Rupture, Penetrating Aortic Ulcer, Aortic Dissection
Vascutek Ltd.
Observational
182
Bologna
2018-05-25
Active, closed
Hoffmann-La Roche
Phase 1/2
211
Naples, Bologna, Bergamo, Milan
2018-05-08
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
Bologna, Florence, Genova, Milan, Monza, Naples, Pesaro, Rionero in Vulture PZ
2018-05-03
Active, closed
Bristol-Myers Squibb
Phase 3
545
Messina, Bologna, Florence, Meldola, Milan, Modena, Monserrato, Naples
2018-04-18
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Bologna, Cagliari, Cento, Messina, Milan, Padova, Roma, Rome
2018-04-13
Active, closed
AbbVie
Phase 3
747
Bologna, Rozzano, Milan, Rome, Negrar, Catania, Catanzaro, Genova
2018-03-21
Active, closed
AstraZeneca
Phase 2
273
Ancona, Bologna, Brescia, Cona, Genova, Lecco, Meldola, Messina
2018-03-07
Recruiting
Octapharma
Observational
200
Bari, Bologna, Castelfranco Veneto, Catania, Florence, Milan, Padova, Rome
2018-02-13
Recruiting
Intraoperative Laxity Assessment of ACL Reconstruction, ACL Revision and MAT
NCT03441165Intraoperative Musculoskeletal Injury
Istituto Ortopedico Rizzoli
Observational
1,500
Bologna
2018-02-10
Active, closed
EBR Systems, Inc.
Not applicable
300
Bologna, Monza
2018-01-17
Active, closed
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
NCT03386513Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm
DrugIMGN632
AbbVie
Phase 1/2
179
Bologna, Meldola, Milan, Perugia
2018-01-02
Recruiting
Istituto Ortopedico Rizzoli
Observational
120
Bologna
2018-01-01
Active, closed
Pfizer
Phase 3
1,054
Bologna, Cremona, Meldola, Terni, Trento, Orbassano, Naples
2017-12-18
Recruiting
Registry for Patients With Lipodystrophy
NCT03553420Lipodystrophy Acquired, Lipodystrophy Congenital
University of Ulm
Observational
5,000
Bologna, Milan, Novara, Palermo, Pisa, Roma
2017-12-16
Active, closed
Sanofi
Phase 3
475
Ancona, Bergamo, Bologna, Brescia, Torino
2017-12-07
Recruiting
Scaffold in Emilia Romagna and in the MAGIC Network
NCT03327961Coronary Artery Disease
University Hospital of Ferrara
Observational
1,111
Agrigento, Treviglio, Bologna, Savigliano, Cona, Forlì, Modena, Parma
2017-12-02
Active, closed
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
530
Ancona, Bologna, Brindisi, Cagliari, Catania, Catanzaro, Cona, Cosenza
2017-11-13
Recruiting
In-hospital Stellate Ganglion Block for Arrhythmic Storm
NCT05720936Arrhythmic Storm, Electrical Storm, Ventricular Fibrillation, Ventricular Tachycardia
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
500
Alessandria, Bentivoglio, Bologna, Pavia, Voghera, Legnago, Ancona, Asti
2017-11-07
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,100
Bologna
2017-09-29
Recruiting
Apollomics Inc.
Phase 2
497
Bologna, Meldola, Milan, Padova
2017-09-27
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Bari, Benevento, Bologna, Brindisi, Cagliari, Florence, Genova, Latina
2017-09-12
Recruiting
Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
NCT04706234Multiple System Atrophy, Parkinson Disease, Progressive Supranuclear Palsy, Motor Neuron Disease
Kliniken Beelitz GmbH
Observational
350
Bologna
2017-09-01
Active, closed
Novartis Pharmaceuticals
Phase 3
206
Bari, Bologna, Pavia, Roma, Siena
2017-08-23
Recruiting
An Observational Study on Epithelioid Sarcoma
NCT03099681Epithelioid Sarcoma
Italian Sarcoma Group
Observational
100
Meldola, Milan, Rozzano, Palermo, Candiolo, Bologna, Padova, Prato
2017-08-22
Active, closed
Medtronic
Observational
1,092
Bologna, Castrovillari, Lecce, Milan, Taranto, Udine
2017-08-21
Active, closed
Murdoch Childrens Research Institute
Phase 3
450
Alessandria, Bologna, Florence, Genova, Milan, Pisa, Roma
2017-08-10
Active, closed
MedSIR
Phase 2
377
Bologna, Brindisi, Cremona, Mantua, Milan, Monza, Piacenza
2017-06-26
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Bari, Bologna, Brescia, Florence, Forlì, Milan, Monza, Naples
2017-06-26
Active, closed
Alliance Foundation Trials, LLC.
Phase 3
518
Bologna, Cona, Milan, Segrate, Udine
2017-06-21
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
Alessandria, Bologna, Brescia, Cremona, Genova, Legnago, Milan, Naples
2017-05-03
Active, closed
Acerta Pharma BV
Phase 3
635
Bologna, Milan, Palermo, Parma, Pavia, Reggio Emilia, Rozzano, Turin
2017-04-05
Recruiting
Italian Sarcoma Group
Not applicable
100
Milan, Bologna, Florence, Pavia, Pisa, Rome, Trento
2017-03-16
Active, closed
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
NCT03069469Advanced Malignant Neoplasm, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor
DrugVimseltinib
Deciphera Pharmaceuticals, LLC
Phase 1/2
120
Bologna, Milan, Rome
2017-02-16
Active, closed
AbbVie
Phase 3
443
Lecce, Rome, Ancona, Bergamo, Bologna, Genova, Milan, Naples
2017-02-02
Active, closed
AbbVie
Phase 3
950
Bologna, Rozzano, Milan, Rho, Rome, Negrar, Palermo
2017-01-31
Recruiting
Registry of Ollier Disease and Maffucci Syndrome
NCT04134572Ollier Disease, Maffucci Syndrome
Luca Sangiorgi
Observational
400
Bologna
2017-01-16
Recruiting
Acute Myocardial Infarction: Prognostic and Therapeutic Evaluation
NCT03883711Acute Coronary Syndrome, Myocardium; Injury
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
11,000
Bologna, Forlì
2017-01-01
Active, closed
Eisai Inc.
Phase 3
1,069
Faenza, Arezzo, Bologna, Genova, Lecce, Meldola, Milan, Modena
2016-10-13
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
NCT02325674Generalised Lipodystrophy, Partial Lipodystrophy
DrugMetreleptin
Chiesi Farmaceutici S.p.A.
Observational
100
Bologna, Pisa, Roma, Novara
2016-10-11
Recruiting
Primary Tumor Research and Outcomes Network
NCT02790983Spinal Column Tumor
AO Innovation Translation Center
Observational
1,350
Bologna, Milan
2016-10
Recruiting
Observational Study on Endometrial Stromal Tumors
NCT02829437Endometrial Stromal Tumors
Italian Sarcoma Group
Observational
100
Meldola, Milan, Palermo, Aviano, Padova, Candiolo, Bologna, Florence
2016-10
Active, closed
Eli Lilly and Company
Phase 2
234
Roma, Negrar, Bologna, Naples
2016-09-14
Active, closed
Acerta Pharma BV
Phase 1
72
Bologna
2016-04-20
Active, closed
Geron Corporation
Phase 2/3
289
Milan, Rozzano, Rionero in Vulture, Roma, Ancona, Bologna, Florence, Reggio Calabria
2016-01-12
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,000
Bologna, Reggio Emilia
2016-01-02
Recruiting
University of Alberta
Observational
900
Bologna
2016-01
Active, closed
Novartis Pharmaceuticals
Phase 4
233
Bergamo, Bologna, Brescia, Meldola, Monza, Milan, Rozzano, Modena
2015-12-11
Active, closed
HyaloFAST Trial for Repair of Articular Cartilage in the Knee
NCT02659215Defect of Articular Cartilage
Anika Therapeutics, Inc.
Not applicable
200
Bologna, Genova, Naples
2015-12
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,105
Bologna, Monza, Milan, Rozzano, Roma
2015-11-02
Active, closed
AstraZeneca
Phase 3
682
Bari, Bergamo, Bologna, Cremona, Florence, Lucca, Meldola, Milan
2015-10-21
Active, closed
Acerta Pharma BV
Phase 3
533
Bologna, Cagliari, Cona, Florence, Meldola, Milan, Modena, Ravenna
2015-07-28
Active, closed
Taiho Oncology, Inc.
Phase 1/2
253
Bologna, Brescia, Milan, Monza
2015-07-14
Active, closed
Medtronic
Observational
3,100
Bari, Bologna, Brescia, Cotignola, Milan, Pisa, Roma
2015-07
Active, closed
Eli Lilly and Company
Phase 3
545
Bari, Aviano, Orbassano, Bologna, Milan, Padova
2015-05-06
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Ancona, Bari, Bologna, Brescia, San Giovanni Rotondo, Florence, Milan, Rozzano
2015-03-05
Active, closed
Acerta Pharma BV
Phase 2
124
Bologna, Meldola, Milan, Novara
2015-03-02
Active, closed
Hoffmann-La Roche
Phase 3
154
Bari, Bologna, Meldola, Reggio Emilia, Milan, Monza, Pisa
2015-02-02
Active, closed
Acerta Pharma BV
Phase 1/2
113
Bologna, Milan, Palermo
2014-12-29
Active, closed
Eli Lilly and Company
Phase 3
493
Brindisi, Cona, Genoa, Candiolo, Prato, Negrar, Bergamo, Bologna
2014-11-06
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Bologna, Florence, Naples, Novara, Rome, Siena, Torino
2014-11
Recruiting
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
NCT02275286Liposarcoma, Myxoid, Sarcoma, Soft Tissue, Leiomyosarcoma, Liposarcoma
DrugTrabectedin
Grupo Espanol de Investigacion en Sarcomas
Phase 1/2
199
Rozzano, Aviano, Bologna, Candiolo, Milan
2014-11
Active, closed
Acerta Pharma BV
Phase 2
107
Bologna, Milan, Novara
2014-09-11
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
1,507
Brixen, Merano, Mirano, Bologna, Bolzano, Ferrara, Reggio Emilia
2014-09
Recruiting
Arrhythmias Detection in a Real World Population
NCT02275637Appropriate and Inappropriate Shock Therapy With ICD, Arrhythmias Detection
Fondazione IRCCS Policlinico San Matteo di Pavia
Observational
10,000
Bergamo, Bologna, Catania, Florence, Milan, Naples, Padua, Pavia
2014-09
Active, closed
AbbVie
Observational
1,446
Milan, Rome, Bologna, Messina, Naples, Palermo, Parma, Pescara
2014-08-28
Active, closed
Eli Lilly and Company
Phase 3
669
Cona, Rome, Bologna, Padova
2014-07-22
Recruiting
Registry of Ehlers-Danlos Syndrome
NCT04133272Ehlers-Danlos Syndrome
Luca Sangiorgi
Observational
3,000
Bologna
2014-06
Active, closed
AstraZeneca
Phase 3
1,837
Bergamo, Bologna, Bolzano, Castellanza Varese, Lecce, Legnago, Milan, Modena
2014-04-22
Active, closed
University of Virginia
Observational
2,750
Bologna, Florence, Milan, Rome
2014-04
Recruiting
Registry of Multiple Osteochondromas
NCT04133285Multiple Osteochondromas
Luca Sangiorgi
Observational
10,000
Bologna
2013-06-28
Recruiting
Registry of Osteogenesis Imperfecta
NCT04115774Osteogenesis Imperfecta
DrugBisphosphonates
Luca Sangiorgi
Observational
5,000
Bologna
2013-06-28
Active, closed
MedImmune LLC
Phase 2
571
Alessandria, Aviano, Bergamo, Bologna, Candiolo, Genova, Meldola, Milan
2013-05-17
Active, closed
AbbVie
Observational
8,250
Bologna, Florence, San Giovanni Rotondo, Genoa, Rozzano, Milan, Naples, Rome
2013-04-29
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Bologna, Florence, Genoa, Monza, Naples, Padova, Pavia, Pisa
2013-04
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Not applicable
540
Alessandria, Ancona, Aviano, Bari, Barletta, Bergamo, Bologna, Bolzano
2012-10
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Milan, Bari, Bologna, Genoa, Naples, Rome
2012-07
Active, closed
Eli Lilly and Company
Phase 2
110
Bologna, Florence
2012-05-22
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Acquaviva delle Fonti, Ancona, Bari, Bologna, Brescia, Caserta, Castrovillari, Cotignola
2012-01
Recruiting
START-Register: Survey on Anticoagulated Patients Register
NCT02219984Atrial Fibrillation, Venous Thromboembolism, Heart Valve Diseases or Prosthesis
GUALTIERO PALARETI
Observational
15,410
Bologna
2011-10
Active, closed
Fondazione del Piemonte per l'Oncologia
Observational
2,500
Aosta, Bologna, Candiolo, Genova, Milan, Orbassano, Padova, Pisa
2011-03-30
Recruiting
Prosthetic Breast Reconstruction After Mastectomy
NCT06774352Breast Reconstruction
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
200
Bologna
2011-01-01
Recruiting
International Survey of Acute Coronary Syndromes
NCT01218776Acute Coronary Syndrome, Unstable Angina Pectoris, Myocardial Infarction, Coronary Disease
University of Bologna
Observational
36,000
Bologna
2010-09-28
Recruiting
Azienda Ospedaliero-Universitaria di Parma
Observational
1,000
Milan, Palermo, Parma, Urbino, Bologna, Carrara, Genova, Naples
2010-09
Recruiting
Global Registry and Natural History Study for Mitochondrial Disorders
NCT05554835Mitochondrial Diseases, Kearns-Sayre Syndrome, MIDD, SANDO
LMU Klinikum
Observational
6,000
Bologna, Brescia, Cagliari, Florence, Genova, Messina, Milan, Pisa
2009-02-01
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
751
Bologna, Milan, Torino
2007-12
Recruiting
Genzyme, a Sanofi Company
Observational
9,000
Florence, Milan, Baggiovara, Monza, Padua, Rome, Bassano del Grappa, Bologna
2001-07-31
Recruiting
Medtronic
Observational
20,000
Ancona, Bari, Bologna, Brescia, Castrovillari, Cotignola, Lecce, Milan
1983-01
Rows per page Showing 1001–1303 of 1303
Previous 1 2 3
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/bologna?page=3

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,303 of those studies with a site in Bologna.

How many clinical trials are recruiting in Bologna?

808 of the 1,303 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 63 have not yet opened recruitment, 418 are active but closed to new participants, and 14 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.